Forecast: Respiratory System Disease Mortality in the US

Based on the data provided, the mortality rate for respiratory system diseases among women in the US has shown a mix of fluctuations over the years, peaking at 87.3 deaths per 100,000 women in 2018. By 2023, the rate stood at 81.0 deaths per 100,000 women. Over the last two years, the mortality rate decreased by 0.97% in 2022 and by 0.98% in 2023. The Compound Annual Growth Rate (CAGR) over the last five years leading to 2023 was -1.49%, indicating a gradual decline in the mortality rate.

Looking ahead, forecast data suggests a continued decline in the mortality rate, with a forecasted 5-year CAGR of -0.5% and an overall reduction of 2.49% by 2028. This trend may be influenced by advancements in medical treatments, increased awareness, and better management of respiratory diseases.

Future trends to watch for:

• Technological advancements in respiratory care and early diagnosis.
• Public health initiatives aimed at reducing smoking rates and improving air quality.
• The impact of emerging therapies and medications on mortality rates.
• Changes in healthcare policies and accessibility.